IMRIS Announces Entrance To Artificial Intelligence Data Market Segment With New IMRIS NeuroBoard Platform
Cloud-based technology allows clinicians and researchers access to powerful data analytics.
MINNETONKA, Minn., Sept. 12, 2018 /PRNewswire/ -- IMRIS, Deerfield Imaging, the leader in image-guided therapy solutions, has entered the AI (Artificial Intelligence) data solution market segment with the release of the new IMRIS NeuroBoard Platform. NeuroBoard, a value-based software platform, is designed to help IMRIS' neurosurgical customer base to improve the effectiveness of key business metrics by providing detailed real-time analytics.
The IMRIS NeuroBoard Platform is a best-in-class, HIPAA compliant cloud architecture built for Neurosurgery organizations across the world. Focused exclusively on Neurosurgery, NeuroBoard allows for preconfigured insights seamlessly integrated from the multiple data sources that exist in Neurosurgery departments. Neurology and neurosurgical teams will be empowered with a deeper understanding of referral patterns, research analysis, profitability measures and procedure level insights. NeuroBoard combines revenue cycle data, clinical and research data into an operational approach leveraging state of the art computing technology that operates at a fraction of the cost of traditional solutions. IMRIS NeuroBoard will enable neurosurgeons to interpret and deliver valuable insights in real time that may otherwise be too time intensive to obtain.
Andy Flanagan, IMRIS CEO stated, "The core mission of IMRIS is to empower neurosurgeons to achieve better outcomes through innovative technology. As IMRIS continues to evolve to better meet the needs of our customers, we must provide more comprehensive solutions that go beyond our traditional hardware and support products. IMRIS is now further empowering our neurosurgeon customers with innovative software solutions."
Leveraging decades of experience, IMRIS continues to support neurosurgical advancements with innovative products and services. The IMRIS Surgical Theater comes in a variety of tailored room configurations with the ceiling-mounted, moveable MRI scanner as the centerpiece. Preferred 3rd party equipment options and premium clinical support are also part of IMRIS' portfolio of customized solutions; however, the IMRIS NeuroBoard Platform is IMRIS' first software offering.
As a leader in image-guided therapy solutions, IMRIS offers the most advanced hybrid surgical theatres with the world's first and only moving ceiling-mounted iMRI and iCT technology that gives neurosurgeons access to high- quality image detail pre-, mid- and post-operation. With a unique symphony of engineering and advanced imaging technology, the IMRIS Surgical Theatre is built for the human experience and inspired by the human mind. IMRIS serves leading hospitals worldwide, offering optimized workflow for surgeons, maximum value for hospitals and better outcomes for patients. As part of its four-pillar business model - Consult, Design, Create and Support - each IMRIS Surgical Theatre is custom-developed for the hospital and surgeons to uniquely compliment their workflow and intended use. For more information, call 763.203.6300, email firstname.lastname@example.org or visit imris.com.
Media Contact: Jill Carrell | email@example.com | 612-812-8828
View original content to download multimedia:http://www.prnewswire.com/news-releases/imris-announces-entrance-to-artificial-intelligence-data-market-segment-with-new-imris-neuroboard-platform-300711525.html